Lenskart vs Titan EyeCare: post-listing scorecard on India's $9.2bn eyewear market
Fresh off its NSE debut, Lenskart is benchmarked against Titan across store reach, manufacturing cost edge, and margins. Lenskart logged 9.3M eye tests and 203 net new stores in H1 FY26 with a 35-40% cost advantage and 69.2% product margin, while Titan EyeCare runs 871 stores but holds under 12% market share.
What happened
Post-listing comparison of Lenskart and Titan EyeCare across India's eyewear market, covering share performance, business models, store reach, manufacturing
Key facts
- Listed Rs 390 vs Rs 402 issue price
- -2.23% past month (Lenskart)
- Titan +0.99% month, +10.85% year
- Market ~$9.2 billion / Rs 30,000 crore
- Titan share <12%
- 9.3M eye tests H1 FY26
- 203 net new stores, 431 cities
- 871 Titan EyeCare stores
- 69.2% product margin
- ~4M frames manufactured H1
- 35-40% cost advantage
Why this matters
Lenskart's vertically integrated manufacturing moat and rapid multi-city expansion make it both an acquisition threat to Titan EyeCare and a benchmark for any eyewear consolidation or partnership play in India.
What to watch
- Q3/FY26 same-store sales growth and store-level EBITDA disclosure
- Titan EyeCare quarterly market share and net store adds
- Lenskart discounting intensity and product-margin trend (watch 69.2% erosion)
- Post-lockup insider selling and institutional flow into the stock
- New store cohort payback and cash burn from expansion
- Lenskart to accelerate tier-2/3 store rollout and push private-label + AI eye-test capacity beyond 9.3M tests
- Titan EyeCare to expand store count and bundle offers via loyalty ecosystem to defend share
- Both to invest in in-house manufacturing/lens tech to protect or close the cost gap
- Analysts to model post-listing profitability trajectory and store-level payback periods